Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Heparin Regimen in Major Vascular Surgery
NCT02477072Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Sep 2015
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of heparin in Peripheral Arterial Disease (PAD) (3 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Anticoagulation upstream and downstream from the clamp. Started Sep 2015; status: completed.
02
Drugs
heparin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02477072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477072.